GeneDx to Introduce Comprehensive Breast Cancer Genetic Test
The company will offer a 27-gene panel for breast and ovarian cancers, and will also provide NGS-based multi-gene panels for other types of cancer.
Read MorePosted by Judy O'Rourke | Jun 24, 2013 | Cancer, Molecular Diagnostics, Pancreatic |
The company will offer a 27-gene panel for breast and ovarian cancers, and will also provide NGS-based multi-gene panels for other types of cancer.
Read MorePosted by Judy O'Rourke | Jun 18, 2013 | Miscellaneous, Molecular Diagnostics |
In a recent blog post from Randy Scott, PhD, CEO, InVitae, he ponders how we can evolve from a society that provides costly reactive health care to one that focuses on preventive medicine.
Read MorePosted by Judy O'Rourke | Jun 13, 2013 | Cancer, Miscellaneous |
Following the Court’s decision, Myriad has more than 500 valid and enforceable claims in 24 different patents conferring strong patent protection for its BRACAnalysis test, the company reports.
Read MorePosted by Judy O'Rourke | Jun 13, 2013 | Miscellaneous |
The decision helps to lay the foundation for continued research and application of diagnosis and treatment of diseases at the molecular level, according to the Association for Molecular Pathology.
Read MorePosted by Judy O'Rourke | Jun 11, 2013 | Molecular Diagnostics |
Schmidt and Gyorgy Abel, MD, PhD, and Natalie N. Whitfield, PhD, will present Molecular Fundamentals: Starting Up and Running a Molecular Lab.
Read More